The goal of this study is to evaluate the health and social benefit of innovative management - IsereADOM - versus conventional follow-up in patients with heart failure.

There is a medico-economic goal too, is to perform a cost-utility analysis of the service bundle (IsereADOM) versus conventional 6-month community-based follow-up in a population with heart failure.

Inclusion Criteria:

• Patient diagnosed with heart failure confirmed by a cardiologist ;
• Patient with functional NYHA II, III, IV staining ;
• Patient domiciled in the department of Isère ;
• Patient who can be followed regularly for 6 months ;
• Patient who can benefit from RESIC-type health education ;
• Presence of a caregiver referent of proximity (family or other) according to appreciation of the investigating doctor in case of cognitive disorders ;
• Patient affiliated with social security or beneficiary of such a scheme ;
• Patient able to read, write and understand French ;
• Patient having signed informed consent to participate.

Exclusion Criteria:

• Patient with peritoneal dialysis or haemofiltration ;
• Patient with severe co-morbidity with poor short-term prognosis: mortality < 6 months ;
• Patient with future surgical etiologic treatment: prosthetic valve, revascularization procedure, TAVI or MITRACLIP ;
• Patient residing in a nursing home or institution for dependent person ;
• Persons referred to in Articles L1121-5 to L1121-8 of the CSP (corresponds to all persons protected: pregnant woman, parturient, mother who is breastfeeding, person deprived of liberty by judicial or administrative decision, person subject of a legal protection measure).